These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 39352255)

  • 1. Recurrent simultaneous central nervous system demyelination with possible peripheral demyelination / nodopathy in a seronegative patient.
    Inan B; Bekircan-Kurt CE; Yildiz FG; Gocmen R; Temucin CM; Tuncer A; Tan E; Erdem-Ozdamar S
    Ideggyogy Sz; 2024 Sep; 77(9-10):357-360. PubMed ID: 39352255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment.
    Cortese A; Franciotta D; Alfonsi E; Visigalli N; Zardini E; Diamanti L; Prunetti P; Osera C; Gastaldi M; Berzero G; Pichiecchio A; Piccolo G; Lozza A; Piscosquito G; Salsano E; Ceroni M; Moglia A; Bono G; Pareyson D; Marchioni E
    J Neurol Sci; 2016 Apr; 363():182-7. PubMed ID: 27000248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Central and Peripheral Demyelination: Two Case Reports.
    Belen BG; Bülbül NG; Karsidag S; Köse E; Vural A; Özdağ F
    Eur Neurol; 2024; 87(2):84-92. PubMed ID: 38325357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nationwide survey of combined central and peripheral demyelination in Japan.
    Ogata H; Matsuse D; Yamasaki R; Kawamura N; Matsushita T; Yonekawa T; Hirotani M; Murai H; Kira J
    J Neurol Neurosurg Psychiatry; 2016 Jan; 87(1):29-36. PubMed ID: 25673872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical features of combined central and peripheral demyelination in Chinese patients.
    Wang YQ; Chen H; Zhuang WP; Li HL
    J Neuroimmunol; 2018 Apr; 317():32-36. PubMed ID: 29501083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-neurofascin antibody in patients with combined central and peripheral demyelination.
    Kawamura N; Yamasaki R; Yonekawa T; Matsushita T; Kusunoki S; Nagayama S; Fukuda Y; Ogata H; Matsuse D; Murai H; Kira J
    Neurology; 2013 Aug; 81(8):714-22. PubMed ID: 23884033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and outcomes of patients with Guillain-Barré and acquired CNS demyelinating overlap syndrome: a cohort study based on a literature review.
    Mao Z; Hu X
    Neurol Res; 2014 Dec; 36(12):1106-13. PubMed ID: 24914906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of Combined Central and Peripheral Demyelination Associated With Antineurofascin 155 Antibodies and Paternal History of Multiple Sclerosis.
    Lambrianides S; Kinnis E; Cleanthous M; Myrianthopoulou P; Leonidou E; Kyriakides T
    Neurologist; 2021 Jul; 26(4):156-159. PubMed ID: 34190211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined central and peripheral demyelination: a case report.
    Costru-Tasnic E; Manole E; Lisnic V
    J Med Life; 2022 Nov; 15(11):1442-1448. PubMed ID: 36567843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurofascin: a novel target for combined central and peripheral demyelination].
    Kawamura N
    Rinsho Shinkeigaku; 2014; 54(12):978-80. PubMed ID: 25672685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism.
    Kira JI
    Front Neurol; 2021; 12():665136. PubMed ID: 34177770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case with Neurofascin-155 IgG antibody-associated combined central and peripheral demyelination: Successfully treated with anti-CD20 monoclonal antibody.
    Sokmen O; Demirci M; Tan E
    Clin Neurol Neurosurg; 2021 Nov; 210():106961. PubMed ID: 34624826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous Guillain-Barré syndrome and acute disseminated encephalomyelitis in the pediatric population.
    Bernard G; Riou E; Rosenblatt B; Dilenge ME; Poulin C
    J Child Neurol; 2008 Jul; 23(7):752-7. PubMed ID: 18354151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [History of Guillain-Barré Syndrome].
    Kusunoki S
    Brain Nerve; 2015 Nov; 67(11):1295-303. PubMed ID: 26560944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes.
    Notturno F; Kokubun N; Sekiguki Y; Nagashima T; De Lauretis A; Yuki N; Kuwabara S; Uncini A
    J Neurol Sci; 2016 Jun; 365():132-6. PubMed ID: 27206890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroids can help distinguish between Guillain-Barré syndrome and first attack of chronic inflammatory demyelinating neuropathy: an illustrative case report.
    Alexander KJ; Alshubaili AF; Santhamoorthy P; Sharafuddin KM
    Med Princ Pract; 2008; 17(5):422-4. PubMed ID: 18685286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.
    van Doorn PA; Van den Bergh PYK; Hadden RDM; Avau B; Vankrunkelsven P; Attarian S; Blomkwist-Markens PH; Cornblath DR; Goedee HS; Harbo T; Jacobs BC; Kusunoki S; Lehmann HC; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Umapathi T; Topaloglu HA; Willison HJ
    J Peripher Nerv Syst; 2023 Dec; 28(4):535-563. PubMed ID: 37814551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.
    van Doorn PA; Van den Bergh PYK; Hadden RDM; Avau B; Vankrunkelsven P; Attarian S; Blomkwist-Markens PH; Cornblath DR; Goedee HS; Harbo T; Jacobs BC; Kusunoki S; Lehmann HC; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Umapathi T; Topaloglu HA; Willison HJ
    Eur J Neurol; 2023 Dec; 30(12):3646-3674. PubMed ID: 37814552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barré syndrome: an update.
    Vucic S; Kiernan MC; Cornblath DR
    J Clin Neurosci; 2009 Jun; 16(6):733-41. PubMed ID: 19356935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Oldest Japanese Case of Combined Central and Peripheral Demyelination, which Developed Nine Years After the First Instance of Optic Neuritis.
    Nomura E; Kawahara Y; Omote Y; Tadokoro K; Takemoto M; Hishikawa N; Yamashita T; Ogata H; Abe K
    Intern Med; 2021 Jan; 60(2):305-308. PubMed ID: 32921691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.